Nachrichten zur Boston Scientific Corp. Aktie

Within Neuromodulation, Boston Scientifics pain business is consistently gaining traction, banking on strength in the spinal cord stimulation (SCS) business.…

Todays Research Daily features new research reports on 16 major stocks, including Boston Scientific Corporation (BSX), Arista Networks, Inc. (ANET)…

Cardiovascular diseases remain the leading global cause of death, taking an estimated 17.9 million lives annually, based on data from…

Boston Scientific pipeline strength fuels quarterly earnings beat…

Barring Neuromodulation, organic and operational revenues at Boston Scientifics (BSX) core business segments rise in the first quarter.…

…

New York (www.aktiencheck.de) - Stryker-Aktienanalyse von Evercore ISI: Die Analysten von Evercore ISI stufen die Aktie von Stryker Corp. (ISIN: US8636671013,…

Boston Scientific (BSX) is expected to have registered strong growth in the Asia Pacific, led by strength in China, Japan…

CODE Der jüngste Kurs betrug 68,40 US-Dollar. Kaum verändert im Vergleich zu der Schlussnotierung vom Vortag zeigt sich derzeit der…

With Boston Scientific (BSX) recording 40% of its sales from the international market, it remains highly exposed to currency fluctuations.…

Passive investing in index funds can generate returns that roughly match the overall market. But in our experience...…

…

Boston Scientific merger with Axonics faces FTC scrutiny…

…

Boston Scientific EVP Wendy Carruthers sells $477,776 in stock…

…

Boston Scientific (BSX) and Scivita Medical announce an expanded strategic cooperation arrangement.…

Scivita Medical broadens ties with Boston Scientific…

Boston Scientific (BSX) is consistently registering fast recovery within its MedSurg segment in the post-pandemic period.…

…

The AGENT DCB of Boston Scientific (BSX) is already available in Europe, parts of Asia Pacific and Latin America.…

Boston Scientific completes €2 billion senior notes offering…